ArticleFrontiers in oncology2026
MemSAM-2.5D: overcoming volumetric discontinuity and boundary ambiguity for 3D liver tumor segmentation.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate segmentation of liver tumors from 3D computed tomography (CT) volumes is essential for the clinical management of hepatocellular carcinoma (HCC), but remains challenging because of extreme lesion-scale variation, volumetric discontinuity across slices, and ambiguous tumor boundaries. Methods: We propose MemSAM-2.5D, a unified 2.5D segmentation framework built upon the MedSAM foundation model. The framework integrates a Hybrid Mamba-Adapter (HMA) for intra-slice multi-scale representation, a Z-axis State Flow (ZSF) module for continuous inter-slice dependency modeling, and a Confidence-Gated Prototype Memory (CGPM) module for uncertainty-aware boundary refinement. Results: Extensive evaluations on MSD08, HCC-TACE-Seg, and WAW-TACE demonstrate that MemSAM-2.5D consistently outperforms representative CNN-based, Transformer-based, Mamba-based, and MedSAM-based baselines. The improvements are reflected not only in overlap-based metrics, but also in boundary-sensitive, lesion-level, and continuity-related measures. Discussion: These results suggest that coordinated modeling of multi-scale lesion variability, z-axis continuity, and boundary ambiguity provides an effective and transferable solution for clinically relevant HCC segmentation in CT volumes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.